Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts

Inhibitors of cell cycle proteins are known to reduce glial activation and to be neuroprotective in a number of settings. In the context of intracerebral grafting, glial activation is documented to correlate with graft rejection. However, the effects of modification of glial reactivity following gra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tomov, Nikola (VerfasserIn) , Surchev, Lachezar (VerfasserIn) , Wiedenmann, Clemens (VerfasserIn) , Döbrössy, Máté D. (VerfasserIn) , Nikkhah, Guido (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 April 2019
In: Experimental neurology
Year: 2019, Jahrgang: 318, Pages: 135-144
ISSN:1090-2430
DOI:10.1016/j.expneurol.2019.04.013
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.expneurol.2019.04.013
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0014488618304254
Volltext
Verfasserangaben:Nikola Tomov, Lachezar Surchev, Clemens Wiedenmann, Máté Döbrösy, Guido Nikkhah

MARC

LEADER 00000caa a2200000 c 4500
001 1671207025
003 DE-627
005 20230428190755.0
007 cr uuu---uuuuu
008 190812s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.expneurol.2019.04.013  |2 doi 
035 |a (DE-627)1671207025 
035 |a (DE-599)KXP1671207025 
035 |a (OCoLC)1341235759 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tomov, Nikola  |e VerfasserIn  |0 (DE-588)170475999  |0 (DE-627)060571616  |0 (DE-576)131360442  |4 aut 
245 1 0 |a Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts  |c Nikola Tomov, Lachezar Surchev, Clemens Wiedenmann, Máté Döbrösy, Guido Nikkhah 
264 1 |c 25 April 2019 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.08.2019 
520 |a Inhibitors of cell cycle proteins are known to reduce glial activation and to be neuroprotective in a number of settings. In the context of intracerebral grafting, glial activation is documented to correlate with graft rejection. However, the effects of modification of glial reactivity following grafting in the CNS are poorly understood. Moreover, it is not completely clear if the glial cells themselves trigger the rejection process, or are they secondarily activated. The present study investigated the effect of microglial inhibition by the cyclin-dependant kinase 5 (CDK5) inhibitor roscovitine following intracerebral transplantation in the rodent model of Parkinson's disease. Single cell suspension of rat E14 ventral mesencephalic tissue was transplanted to the dopamine-depleted striatum of unilaterally 6-hydroxydopamine (6-OHDA) lesioned male Sprague-Dawley rats. Experimental animals received injections of roscovitine (20mg/kg) or a vehicle solution three times following the procedure. Immunohistochemistry was carried out on Day 7 and Day 28 to quantitatively describe the glial reaction adjacent to grafts. The data confirm that systemic roscovitine treatment significantly reduced microglial recruitment adjacent to the grafts on Day 28, without exhibiting significant effects on astroglia. However, this was not found to correlate with elevated numbers of neurons in the grafts. Moreover, microglial reaction surrounding grafts was less pronounced compared to control animals, subjected to the mechanical influence only, even without roscovitine treatment. Our results are the first to show the effect of cell cycle inhibition in the context of neuronal transplantation. The findings suggest that microglial activation around intracerebral grafts can be modified pharmacologically. However, the results do not confirm direct neuroprotective effects of cell cycle inhibition after intracerebral transplantation. Reducing microglial recruitment around grafts could be beneficial by reducing inflammation-related degenerative processes. Sparing astrocytes in the same time provides transplanted cells with essential trophics and support. We consider microglial inhibition to be a possible approach for reducing later graft-related complications. 
650 4 |a Astroglia 
650 4 |a CDK5 
650 4 |a Microglia 
650 4 |a Parkinson's disease 
650 4 |a Roscovitine 
650 4 |a Transplantation 
700 1 |a Surchev, Lachezar  |e VerfasserIn  |4 aut 
700 1 |a Wiedenmann, Clemens  |d 1987-  |e VerfasserIn  |0 (DE-588)1186002697  |0 (DE-627)1665290560  |4 aut 
700 1 |a Döbrössy, Máté D.  |e VerfasserIn  |0 (DE-588)1080528288  |0 (DE-627)844769851  |0 (DE-576)453593445  |4 aut 
700 1 |a Nikkhah, Guido  |d 1961-  |e VerfasserIn  |0 (DE-588)141829710  |0 (DE-627)704072823  |0 (DE-576)168236559  |4 aut 
773 0 8 |i Enthalten in  |t Experimental neurology  |d Amsterdam [u.a.] : Elsevier, 1959  |g 318(2019), Seite 135-144  |h Online-Ressource  |w (DE-627)266018106  |w (DE-600)1466932-8  |w (DE-576)106845926  |x 1090-2430  |7 nnas  |a Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts 
773 1 8 |g volume:318  |g year:2019  |g pages:135-144  |g extent:10  |a Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts 
856 4 0 |u https://doi.org/10.1016/j.expneurol.2019.04.013  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0014488618304254  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190812 
993 |a Article 
994 |a 2019 
998 |g 170475999  |a Tomov, Nikola  |m 170475999:Tomov, Nikola  |d 60000  |e 60000PT170475999  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1671207025  |e 3506500864 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Nikola","family":"Tomov","role":"aut","display":"Tomov, Nikola","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Surchev, Lachezar","roleDisplay":"VerfasserIn","given":"Lachezar","family":"Surchev"},{"display":"Wiedenmann, Clemens","roleDisplay":"VerfasserIn","role":"aut","family":"Wiedenmann","given":"Clemens"},{"display":"Döbrössy, Máté D.","roleDisplay":"VerfasserIn","role":"aut","family":"Döbrössy","given":"Máté D."},{"given":"Guido","family":"Nikkhah","role":"aut","roleDisplay":"VerfasserIn","display":"Nikkhah, Guido"}],"title":[{"title":"Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts","title_sort":"Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts"}],"note":["Gesehen am 12.08.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1671207025","language":["eng"],"name":{"displayForm":["Nikola Tomov, Lachezar Surchev, Clemens Wiedenmann, Máté Döbrösy, Guido Nikkhah"]},"origin":[{"dateIssuedDisp":"25 April 2019","dateIssuedKey":"2019"}],"id":{"eki":["1671207025"],"doi":["10.1016/j.expneurol.2019.04.013"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"title":"Experimental neurology","subtitle":"a journal of neuroscience research","title_sort":"Experimental neurology"}],"part":{"pages":"135-144","year":"2019","extent":"10","text":"318(2019), Seite 135-144","volume":"318"},"pubHistory":["1.1959 -"],"recId":"266018106","language":["eng"],"disp":"Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic graftsExperimental neurology","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 05.02.20"],"id":{"issn":["1090-2430"],"zdb":["1466932-8"],"eki":["266018106"]},"origin":[{"dateIssuedDisp":"1959-","publisher":"Elsevier ; Academic Press","dateIssuedKey":"1959","publisherPlace":"Amsterdam [u.a.] ; Orlando, Fla."}],"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a TOMOVNIKOLROSCOVITIN2520